| Sno |
Abstract Title |
Abstract Type |
Edit |
Delete |
| 1 |
The PVSG/WHO versus the clinical, laboratory, molecular and pathological (2018 CLMP) defined myeloproliferative neoplasms caused by JAK2V617F JAK2EXON12, CALR, MPL and TPO driver mutations are distinct blood & coagulation disorders: Prognostic and therapeutic implications towards 2020 and beyond
Jan Jacques Michiels
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 2 |
The mitotic kinase Aurora kinase A localises to mitochondria to control organelle dynamics and energy production: Implication for cancer cells overexpressing Aurora-A
Claude Prigent
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 3 |
Targeting RSK4 prevents both chemoresistance and metastasis in lung and bladder cancer: Potential of re-purposed floxacins as novel therapeutic agents
Olivier E Pardo
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 4 |
Finally we have positive data in the treatment of breast cancer using ICI
Stefan Glueck
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 5 |
Effects of far-infrared & terahertz Onnetsu therapy on various cancers, rheumatoid arthritis and other diseases
Kazuko Tatsumura
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 6 |
Disease modifying non-opioid analgesic for chemotherapy induced peripheral neuropathy (CIPN)
Raghavan Rajagopalan
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 7 |
Change of the 2008/16 WHO into 2018 clinical, laboratory, molecular and pathobiological (WHO-CLMP) criteria for diagnosis of the meloproliferative neoplasms JAK2V617F trilinear polycythemia vera (PV), JAK2 exon 12 PV and JAK2V617F, CALR or MPL515 mutated thrombocythemias and secondary myelofibrosis
Jan Jacques Michiels
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 8 |
Cancer metastasis from the primary site to the sentinel lymph nodes and beyond in relationship to the immune system
Stanley P L Leong
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 9 |
Cancer and peripheral deep vein thrombosis are both independent diseases: Causes, pathogenesis, conclusions
Elena Drozdova
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|
| 10 |
A prior activation of apoptosis pathways of tumor (AAAPT) technology: Biomarker for the risk stratification of cancer patients
Raghu Pandurangi
HTML | PDF |
Add Speaker+
[1 ]
|
Keynote |
|
|